LEMAITRE VASCULAR INC (LMAT) Fundamental Analysis & Valuation
NASDAQ:LMAT • US5255582018
Current stock price
112.41 USD
+2.08 (+1.89%)
At close:
112.41 USD
0 (0%)
After Hours:
This LMAT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. LMAT Profitability Analysis
1.1 Basic Checks
- LMAT had positive earnings in the past year.
- LMAT had a positive operating cash flow in the past year.
- LMAT had positive earnings in each of the past 5 years.
- Each year in the past 5 years LMAT had a positive operating cash flow.
1.2 Ratios
- LMAT has a Return On Assets of 9.38%. This is amongst the best in the industry. LMAT outperforms 89.89% of its industry peers.
- With an excellent Return On Equity value of 14.67%, LMAT belongs to the best of the industry, outperforming 89.89% of the companies in the same industry.
- LMAT's Return On Invested Capital of 9.04% is amongst the best of the industry. LMAT outperforms 87.23% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for LMAT is in line with the industry average of 9.40%.
- The last Return On Invested Capital (9.04%) for LMAT is above the 3 year average (8.61%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.38% | ||
| ROE | 14.67% | ||
| ROIC | 9.04% |
ROA(3y)8.68%
ROA(5y)8.37%
ROE(3y)12.61%
ROE(5y)11.22%
ROIC(3y)8.61%
ROIC(5y)8.85%
1.3 Margins
- With an excellent Profit Margin value of 23.13%, LMAT belongs to the best of the industry, outperforming 95.21% of the companies in the same industry.
- In the last couple of years the Profit Margin of LMAT has grown nicely.
- The Operating Margin of LMAT (27.21%) is better than 96.28% of its industry peers.
- In the last couple of years the Operating Margin of LMAT has grown nicely.
- LMAT has a Gross Margin of 71.53%. This is amongst the best in the industry. LMAT outperforms 81.91% of its industry peers.
- In the last couple of years the Gross Margin of LMAT has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 27.21% | ||
| PM (TTM) | 23.13% | ||
| GM | 71.53% |
OM growth 3Y13.74%
OM growth 5Y4.46%
PM growth 3Y22%
PM growth 5Y7.14%
GM growth 3Y3.31%
GM growth 5Y1.81%
2. LMAT Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so LMAT is still creating some value.
- Compared to 1 year ago, LMAT has more shares outstanding
- LMAT has more shares outstanding than it did 5 years ago.
- Compared to 1 year ago, LMAT has an improved debt to assets ratio.
2.2 Solvency
- LMAT has an Altman-Z score of 8.82. This indicates that LMAT is financially healthy and has little risk of bankruptcy at the moment.
- LMAT has a better Altman-Z score (8.82) than 85.64% of its industry peers.
- The Debt to FCF ratio of LMAT is 2.26, which is a good value as it means it would take LMAT, 2.26 years of fcf income to pay off all of its debts.
- With an excellent Debt to FCF ratio value of 2.26, LMAT belongs to the best of the industry, outperforming 85.64% of the companies in the same industry.
- A Debt/Equity ratio of 0.43 indicates that LMAT is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.43, LMAT is in line with its industry, outperforming 45.21% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 2.26 | ||
| Altman-Z | 8.82 |
ROIC/WACC1.04
WACC8.65%
2.3 Liquidity
- A Current Ratio of 12.89 indicates that LMAT has no problem at all paying its short term obligations.
- LMAT has a better Current ratio (12.89) than 97.34% of its industry peers.
- A Quick Ratio of 10.95 indicates that LMAT has no problem at all paying its short term obligations.
- The Quick ratio of LMAT (10.95) is better than 96.81% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 12.89 | ||
| Quick Ratio | 10.95 |
3. LMAT Growth Analysis
3.1 Past
- LMAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.68%, which is quite impressive.
- The Earnings Per Share has been growing by 17.12% on average over the past years. This is quite good.
- The Revenue has grown by 13.53% in the past year. This is quite good.
- Measured over the past years, LMAT shows a quite strong growth in Revenue. The Revenue has been growing by 14.04% on average per year.
EPS 1Y (TTM)22.68%
EPS 3Y36.78%
EPS 5Y17.12%
EPS Q2Q%38.78%
Revenue 1Y (TTM)13.53%
Revenue growth 3Y15.57%
Revenue growth 5Y14.04%
Sales Q2Q%15.68%
3.2 Future
- The Earnings Per Share is expected to grow by 11.37% on average over the next years. This is quite good.
- Based on estimates for the next years, LMAT will show a quite strong growth in Revenue. The Revenue will grow by 9.67% on average per year.
EPS Next Y20.86%
EPS Next 2Y15.35%
EPS Next 3Y12.89%
EPS Next 5Y11.37%
Revenue Next Year12.71%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y9.67%
3.3 Evolution
- The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. LMAT Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 47.23, LMAT can be considered very expensive at the moment.
- Based on the Price/Earnings ratio, LMAT is valued a bit cheaper than the industry average as 68.09% of the companies are valued more expensively.
- LMAT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.21.
- A Price/Forward Earnings ratio of 39.08 indicates a quite expensive valuation of LMAT.
- 70.74% of the companies in the same industry are more expensive than LMAT, based on the Price/Forward Earnings ratio.
- LMAT's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.10.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.23 | ||
| Fwd PE | 39.08 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, LMAT is valued a bit cheaper than the industry average as 71.28% of the companies are valued more expensively.
- 76.60% of the companies in the same industry are more expensive than LMAT, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 34.39 | ||
| EV/EBITDA | 25.43 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates LMAT does not grow enough to justify the current Price/Earnings ratio.
- The excellent profitability rating of LMAT may justify a higher PE ratio.
- LMAT's earnings are expected to grow with 12.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.26
PEG (5Y)2.76
EPS Next 2Y15.35%
EPS Next 3Y12.89%
5. LMAT Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.94%, LMAT is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.25, LMAT pays a better dividend. On top of this LMAT pays more dividend than 91.49% of the companies listed in the same industry.
- Compared to an average S&P500 Dividend Yield of 1.89, LMAT's dividend is way lower than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
5.2 History
- On average, the dividend of LMAT grows each year by 16.13%, which is quite nice.
- LMAT has paid a dividend for at least 10 years, which is a reliable track record.
- LMAT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)16.13%
Div Incr Years14
Div Non Decr Years14
5.3 Sustainability
- LMAT pays out 31.37% of its income as dividend. This is a sustainable payout ratio.
- The dividend of LMAT is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP31.37%
EPS Next 2Y15.35%
EPS Next 3Y12.89%
LMAT Fundamentals: All Metrics, Ratios and Statistics
112.41
+2.08 (+1.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)04-30 2026-04-30
Inst Owners96.24%
Inst Owner Change0%
Ins Owners7.97%
Ins Owner Change-9.98%
Market Cap2.56B
Revenue(TTM)249.60M
Net Income(TTM)57.73M
Analysts80
Price Target112.71 (0.27%)
Short Float %5.95%
Short Ratio5.54
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.94% |
Yearly Dividend0.8
Dividend Growth(5Y)16.13%
DP31.37%
Div Incr Years14
Div Non Decr Years14
Ex-Date03-12 2026-03-12 (0.25)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)3.9%
Min EPS beat(2)0.42%
Max EPS beat(2)7.38%
EPS beat(4)3
Avg EPS beat(4)1.52%
Min EPS beat(4)-5.52%
Max EPS beat(4)7.38%
EPS beat(8)6
Avg EPS beat(8)4.19%
EPS beat(12)10
Avg EPS beat(12)5.13%
EPS beat(16)10
Avg EPS beat(16)-0.04%
Revenue beat(2)1
Avg Revenue beat(2)-1.58%
Min Revenue beat(2)-3.74%
Max Revenue beat(2)0.58%
Revenue beat(4)3
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-3.74%
Max Revenue beat(4)1.83%
Revenue beat(8)5
Avg Revenue beat(8)-0.14%
Revenue beat(12)7
Avg Revenue beat(12)0.21%
Revenue beat(16)8
Avg Revenue beat(16)-0.25%
PT rev (1m)6.59%
PT rev (3m)6.59%
EPS NQ rev (1m)0.43%
EPS NQ rev (3m)7.26%
EPS NY rev (1m)0%
EPS NY rev (3m)9.01%
Revenue NQ rev (1m)0.02%
Revenue NQ rev (3m)1.1%
Revenue NY rev (1m)0.49%
Revenue NY rev (3m)3.22%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 47.23 | ||
| Fwd PE | 39.08 | ||
| P/S | 10.26 | ||
| P/FCF | 34.39 | ||
| P/OCF | 31.52 | ||
| P/B | 6.51 | ||
| P/tB | 8.7 | ||
| EV/EBITDA | 25.43 |
EPS(TTM)2.38
EY2.12%
EPS(NY)2.88
Fwd EY2.56%
FCF(TTM)3.27
FCFY2.91%
OCF(TTM)3.57
OCFY3.17%
SpS10.96
BVpS17.27
TBVpS12.93
PEG (NY)2.26
PEG (5Y)2.76
Graham Number30.41
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.38% | ||
| ROE | 14.67% | ||
| ROCE | 11.72% | ||
| ROIC | 9.04% | ||
| ROICexc | 23.78% | ||
| ROICexgc | 43.2% | ||
| OM | 27.21% | ||
| PM (TTM) | 23.13% | ||
| GM | 71.53% | ||
| FCFM | 29.83% |
ROA(3y)8.68%
ROA(5y)8.37%
ROE(3y)12.61%
ROE(5y)11.22%
ROIC(3y)8.61%
ROIC(5y)8.85%
ROICexc(3y)18.5%
ROICexc(5y)16.17%
ROICexgc(3y)34.8%
ROICexgc(5y)32.81%
ROCE(3y)11.16%
ROCE(5y)11.48%
ROICexgc growth 3Y19.07%
ROICexgc growth 5Y8.49%
ROICexc growth 3Y27.82%
ROICexc growth 5Y16.94%
OM growth 3Y13.74%
OM growth 5Y4.46%
PM growth 3Y22%
PM growth 5Y7.14%
GM growth 3Y3.31%
GM growth 5Y1.81%
F-Score7
Asset Turnover0.41
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 2.26 | ||
| Debt/EBITDA | 2.15 | ||
| Cap/Depr | 65.11% | ||
| Cap/Sales | 2.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 103.73% | ||
| Profit Quality | 128.99% | ||
| Current Ratio | 12.89 | ||
| Quick Ratio | 10.95 | ||
| Altman-Z | 8.82 |
F-Score7
WACC8.65%
ROIC/WACC1.04
Cap/Depr(3y)71.15%
Cap/Depr(5y)58.36%
Cap/Sales(3y)3.21%
Cap/Sales(5y)2.96%
Profit Quality(3y)103.77%
Profit Quality(5y)106.24%
High Growth Momentum
Growth
EPS 1Y (TTM)22.68%
EPS 3Y36.78%
EPS 5Y17.12%
EPS Q2Q%38.78%
EPS Next Y20.86%
EPS Next 2Y15.35%
EPS Next 3Y12.89%
EPS Next 5Y11.37%
Revenue 1Y (TTM)13.53%
Revenue growth 3Y15.57%
Revenue growth 5Y14.04%
Sales Q2Q%15.68%
Revenue Next Year12.71%
Revenue Next 2Y10.78%
Revenue Next 3Y10.08%
Revenue Next 5Y9.67%
EBIT growth 1Y29.96%
EBIT growth 3Y31.45%
EBIT growth 5Y19.13%
EBIT Next Year38.55%
EBIT Next 3Y19.89%
EBIT Next 5Y16.94%
FCF growth 1Y100.39%
FCF growth 3Y49.81%
FCF growth 5Y18.54%
OCF growth 1Y84.14%
OCF growth 3Y47.38%
OCF growth 5Y18.48%
LEMAITRE VASCULAR INC / LMAT Fundamental Analysis FAQ
What is the ChartMill fundamental rating of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a fundamental rating of 7 / 10 to LMAT.
What is the valuation status of LEMAITRE VASCULAR INC (LMAT) stock?
ChartMill assigns a valuation rating of 4 / 10 to LEMAITRE VASCULAR INC (LMAT). This can be considered as Fairly Valued.
Can you provide the profitability details for LEMAITRE VASCULAR INC?
LEMAITRE VASCULAR INC (LMAT) has a profitability rating of 9 / 10.
What is the expected EPS growth for LEMAITRE VASCULAR INC (LMAT) stock?
The Earnings per Share (EPS) of LEMAITRE VASCULAR INC (LMAT) is expected to grow by 20.86% in the next year.
Can you provide the dividend sustainability for LMAT stock?
The dividend rating of LEMAITRE VASCULAR INC (LMAT) is 6 / 10 and the dividend payout ratio is 31.37%.